跳至主要内容
临床试验/IRCT201611306699N3
IRCT201611306699N3已完成未知

Therapeutic effect of intra tympanic injection of Dexamethasone-Hyaluronic acid combination in comparison with intra tympanic Dexamethasone in sudden sensorineural hearing loss

Vice Chancellor for Research, Isfahan University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • The inclusion criteria consisted of unilateral hearing loss (occurring within 72 hours), the hearing threshold average greater than 50 dB, symptoms appearance within 7 days from our intervention, patient's pure tone audiogram at frequencies 250 500, 1000, 2000, 4000 and 8000 Hz, age range 18-80 years, lack of acoustic tumor, middle ear diseases, autoimmune diseases, vestibular problem (Menier disease&..), cardiovascular disorders and diabetes, no history of ear surgery and the patient’s consent to participate in the study.
  • Meanwhile patient’s refusal to attend on time for follow up visits, any limitation to inject intra tympanum via external auditory canal such as stenosis, anatomical deformities and external and middle ear infections were considered as exclusion criteria.

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for Research, Isfahan University of Medical Sciences

相似试验